Global Electrophoresis
Global Electrophoresis

Electrophoresis Comprehensive Study by Type (Electrophoresis Reagents, Gel Electrophoresis Systems (Horizontal Gel Electrophoresis Instrument, Vertical Gel Electrophoresis Instrument, Polyacrylamide Gel Electrophoresis, Agarose Gel Electrophoresis), Capillary Electrophoresis Systems, Gel Documentation Systems, Software), Application (Diagnostic, Research, Quality Control, Process Validation), End Users (Academic Institutions, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Research Organizations) Players and Region - Global Market Outlook to 2024

Electrophoresis Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Nov 2019 Edition 217 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Electrophoresis is a process that separates the charged particles by using an electrical charge in a fluid. It is used for the separation of protein molecules or DNA in life sciences. It can be achieved using different procedures and also depends on the type of molecules. It uses different reagents for separation of molecules such as dyes, gels, and buffers. The electrophoresis is widely used in medical diagnostics, life sciences and clinical research. These applications are creating a demand of electrophoresis.

The market study is being classified by Type (Electrophoresis Reagents, Gel Electrophoresis Systems (Horizontal Gel Electrophoresis Instrument, Vertical Gel Electrophoresis Instrument, Polyacrylamide Gel Electrophoresis, Agarose Gel Electrophoresis), Capillary Electrophoresis Systems, Gel Documentation Systems and Software), by Application (Diagnostic, Research, Quality Control and Process Validation) and major geographies with country level break-up.

Bio-Rad Laboratories (United States), GE Healthcare (United States), Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Agilent Technologies (United States), Merck Millipore (United States), PerkinElmer, Inc. (United States), QIAGEN N.V. (Germany), Lonza Group Ltd. (Switzerland) and Shimadzu Corporation (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Harvard Bioscience, Inc. (United Sates) and C.B.S. Scientific Company, Inc. (United States).

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Electrophoresis market by Type, Application and Region.

On the basis of geography, the market of Electrophoresis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Raising Prevalence of Diseases Such as Cancer, Infectious Diseases, and Genetic Disorders
  • Growing Need of Separation of Cancer Proteins in Various Research and Development Organisations.

Market Trend
  • Rising Adoption of Capillary Electrophoresis among the Chemical Industries

Restraints
  • Increasing Number of Research Laboratories

Opportunities
  • Increasing Investments in Research and Developments
  • Rising Integration and Collaboration among Various Industries

Challenges
  • Availability of Alternative Technology may hamper the Market Growth


Market Leaders and their expansionary development strategies
In May 2019, Thermo Fisher Scientific has acquired Brammer Bio which deals with viral vector manufacturing of gene and cell therapies.



Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Electrophoresis Reagents
  • Gel Electrophoresis Systems (Horizontal Gel Electrophoresis Instrument, Vertical Gel Electrophoresis Instrument, Polyacrylamide Gel Electrophoresis, Agarose Gel Electrophoresis)
  • Capillary Electrophoresis Systems
  • Gel Documentation Systems
  • Software
By Application
  • Diagnostic
  • Research
  • Quality Control
  • Process Validation
By End Users
  • Academic Institutions
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Research Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Raising Prevalence of Diseases Such as Cancer, Infectious Diseases, and Genetic Disorders
      • 3.2.2. Growing Need of Separation of Cancer Proteins in Various Research and Development Organisations.
    • 3.3. Market Challenges
      • 3.3.1. Availability of Alternative Technology may hamper the Market Growth
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of Capillary Electrophoresis among the Chemical Industries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Electrophoresis, by Type, Application, End Users and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Electrophoresis (Value)
      • 5.2.1. Global Electrophoresis by: Type (Value)
        • 5.2.1.1. Electrophoresis Reagents
        • 5.2.1.2. Gel Electrophoresis Systems (Horizontal Gel Electrophoresis Instrument, Vertical Gel Electrophoresis Instrument, Polyacrylamide Gel Electrophoresis, Agarose Gel Electrophoresis)
        • 5.2.1.3. Capillary Electrophoresis Systems
        • 5.2.1.4. Gel Documentation Systems
        • 5.2.1.5. Software
      • 5.2.2. Global Electrophoresis by: Application (Value)
        • 5.2.2.1. Diagnostic
        • 5.2.2.2. Research
        • 5.2.2.3. Quality Control
        • 5.2.2.4. Process Validation
      • 5.2.3. Global Electrophoresis by: End Users (Value)
        • 5.2.3.1. Academic Institutions
        • 5.2.3.2. Hospitals & Diagnostic Centers
        • 5.2.3.3. Pharmaceutical & Biotechnology Companies
        • 5.2.3.4. Research Organizations
      • 5.2.4. Global Electrophoresis Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Electrophoresis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GE Healthcare (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agilent Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck Millipore (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PerkinElmer, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. QIAGEN N.V. (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lonza Group Ltd. (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Shimadzu Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Electrophoresis Sale, by Type, Application, End Users and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Electrophoresis (Value)
      • 7.2.1. Global Electrophoresis by: Type (Value)
        • 7.2.1.1. Electrophoresis Reagents
        • 7.2.1.2. Gel Electrophoresis Systems (Horizontal Gel Electrophoresis Instrument, Vertical Gel Electrophoresis Instrument, Polyacrylamide Gel Electrophoresis, Agarose Gel Electrophoresis)
        • 7.2.1.3. Capillary Electrophoresis Systems
        • 7.2.1.4. Gel Documentation Systems
        • 7.2.1.5. Software
      • 7.2.2. Global Electrophoresis by: Application (Value)
        • 7.2.2.1. Diagnostic
        • 7.2.2.2. Research
        • 7.2.2.3. Quality Control
        • 7.2.2.4. Process Validation
      • 7.2.3. Global Electrophoresis by: End Users (Value)
        • 7.2.3.1. Academic Institutions
        • 7.2.3.2. Hospitals & Diagnostic Centers
        • 7.2.3.3. Pharmaceutical & Biotechnology Companies
        • 7.2.3.4. Research Organizations
      • 7.2.4. Global Electrophoresis Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Electrophoresis: by Type(USD Million)
  • Table 2. Electrophoresis Electrophoresis Reagents , by Region USD Million (2013-2018)
  • Table 3. Electrophoresis Gel Electrophoresis Systems (Horizontal Gel Electrophoresis Instrument, Vertical Gel Electrophoresis Instrument, Polyacrylamide Gel Electrophoresis, Agarose Gel Electrophoresis) , by Region USD Million (2013-2018)
  • Table 4. Electrophoresis Capillary Electrophoresis Systems , by Region USD Million (2013-2018)
  • Table 5. Electrophoresis Gel Documentation Systems , by Region USD Million (2013-2018)
  • Table 6. Electrophoresis Software , by Region USD Million (2013-2018)
  • Table 7. Electrophoresis: by Application(USD Million)
  • Table 8. Electrophoresis Diagnostic , by Region USD Million (2013-2018)
  • Table 9. Electrophoresis Research , by Region USD Million (2013-2018)
  • Table 10. Electrophoresis Quality Control , by Region USD Million (2013-2018)
  • Table 11. Electrophoresis Process Validation , by Region USD Million (2013-2018)
  • Table 12. Electrophoresis: by End Users(USD Million)
  • Table 13. Electrophoresis Academic Institutions , by Region USD Million (2013-2018)
  • Table 14. Electrophoresis Hospitals & Diagnostic Centers , by Region USD Million (2013-2018)
  • Table 15. Electrophoresis Pharmaceutical & Biotechnology Companies , by Region USD Million (2013-2018)
  • Table 16. Electrophoresis Research Organizations , by Region USD Million (2013-2018)
  • Table 17. South America Electrophoresis, by Country USD Million (2013-2018)
  • Table 18. South America Electrophoresis, by Type USD Million (2013-2018)
  • Table 19. South America Electrophoresis, by Application USD Million (2013-2018)
  • Table 20. South America Electrophoresis, by End Users USD Million (2013-2018)
  • Table 21. Brazil Electrophoresis, by Type USD Million (2013-2018)
  • Table 22. Brazil Electrophoresis, by Application USD Million (2013-2018)
  • Table 23. Brazil Electrophoresis, by End Users USD Million (2013-2018)
  • Table 24. Argentina Electrophoresis, by Type USD Million (2013-2018)
  • Table 25. Argentina Electrophoresis, by Application USD Million (2013-2018)
  • Table 26. Argentina Electrophoresis, by End Users USD Million (2013-2018)
  • Table 27. Rest of South America Electrophoresis, by Type USD Million (2013-2018)
  • Table 28. Rest of South America Electrophoresis, by Application USD Million (2013-2018)
  • Table 29. Rest of South America Electrophoresis, by End Users USD Million (2013-2018)
  • Table 30. Asia Pacific Electrophoresis, by Country USD Million (2013-2018)
  • Table 31. Asia Pacific Electrophoresis, by Type USD Million (2013-2018)
  • Table 32. Asia Pacific Electrophoresis, by Application USD Million (2013-2018)
  • Table 33. Asia Pacific Electrophoresis, by End Users USD Million (2013-2018)
  • Table 34. China Electrophoresis, by Type USD Million (2013-2018)
  • Table 35. China Electrophoresis, by Application USD Million (2013-2018)
  • Table 36. China Electrophoresis, by End Users USD Million (2013-2018)
  • Table 37. Japan Electrophoresis, by Type USD Million (2013-2018)
  • Table 38. Japan Electrophoresis, by Application USD Million (2013-2018)
  • Table 39. Japan Electrophoresis, by End Users USD Million (2013-2018)
  • Table 40. India Electrophoresis, by Type USD Million (2013-2018)
  • Table 41. India Electrophoresis, by Application USD Million (2013-2018)
  • Table 42. India Electrophoresis, by End Users USD Million (2013-2018)
  • Table 43. South Korea Electrophoresis, by Type USD Million (2013-2018)
  • Table 44. South Korea Electrophoresis, by Application USD Million (2013-2018)
  • Table 45. South Korea Electrophoresis, by End Users USD Million (2013-2018)
  • Table 46. Taiwan Electrophoresis, by Type USD Million (2013-2018)
  • Table 47. Taiwan Electrophoresis, by Application USD Million (2013-2018)
  • Table 48. Taiwan Electrophoresis, by End Users USD Million (2013-2018)
  • Table 49. Australia Electrophoresis, by Type USD Million (2013-2018)
  • Table 50. Australia Electrophoresis, by Application USD Million (2013-2018)
  • Table 51. Australia Electrophoresis, by End Users USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Electrophoresis, by Type USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Electrophoresis, by Application USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Electrophoresis, by End Users USD Million (2013-2018)
  • Table 55. Europe Electrophoresis, by Country USD Million (2013-2018)
  • Table 56. Europe Electrophoresis, by Type USD Million (2013-2018)
  • Table 57. Europe Electrophoresis, by Application USD Million (2013-2018)
  • Table 58. Europe Electrophoresis, by End Users USD Million (2013-2018)
  • Table 59. Germany Electrophoresis, by Type USD Million (2013-2018)
  • Table 60. Germany Electrophoresis, by Application USD Million (2013-2018)
  • Table 61. Germany Electrophoresis, by End Users USD Million (2013-2018)
  • Table 62. France Electrophoresis, by Type USD Million (2013-2018)
  • Table 63. France Electrophoresis, by Application USD Million (2013-2018)
  • Table 64. France Electrophoresis, by End Users USD Million (2013-2018)
  • Table 65. Italy Electrophoresis, by Type USD Million (2013-2018)
  • Table 66. Italy Electrophoresis, by Application USD Million (2013-2018)
  • Table 67. Italy Electrophoresis, by End Users USD Million (2013-2018)
  • Table 68. United Kingdom Electrophoresis, by Type USD Million (2013-2018)
  • Table 69. United Kingdom Electrophoresis, by Application USD Million (2013-2018)
  • Table 70. United Kingdom Electrophoresis, by End Users USD Million (2013-2018)
  • Table 71. Netherlands Electrophoresis, by Type USD Million (2013-2018)
  • Table 72. Netherlands Electrophoresis, by Application USD Million (2013-2018)
  • Table 73. Netherlands Electrophoresis, by End Users USD Million (2013-2018)
  • Table 74. Rest of Europe Electrophoresis, by Type USD Million (2013-2018)
  • Table 75. Rest of Europe Electrophoresis, by Application USD Million (2013-2018)
  • Table 76. Rest of Europe Electrophoresis, by End Users USD Million (2013-2018)
  • Table 77. MEA Electrophoresis, by Country USD Million (2013-2018)
  • Table 78. MEA Electrophoresis, by Type USD Million (2013-2018)
  • Table 79. MEA Electrophoresis, by Application USD Million (2013-2018)
  • Table 80. MEA Electrophoresis, by End Users USD Million (2013-2018)
  • Table 81. Middle East Electrophoresis, by Type USD Million (2013-2018)
  • Table 82. Middle East Electrophoresis, by Application USD Million (2013-2018)
  • Table 83. Middle East Electrophoresis, by End Users USD Million (2013-2018)
  • Table 84. Africa Electrophoresis, by Type USD Million (2013-2018)
  • Table 85. Africa Electrophoresis, by Application USD Million (2013-2018)
  • Table 86. Africa Electrophoresis, by End Users USD Million (2013-2018)
  • Table 87. North America Electrophoresis, by Country USD Million (2013-2018)
  • Table 88. North America Electrophoresis, by Type USD Million (2013-2018)
  • Table 89. North America Electrophoresis, by Application USD Million (2013-2018)
  • Table 90. North America Electrophoresis, by End Users USD Million (2013-2018)
  • Table 91. United States Electrophoresis, by Type USD Million (2013-2018)
  • Table 92. United States Electrophoresis, by Application USD Million (2013-2018)
  • Table 93. United States Electrophoresis, by End Users USD Million (2013-2018)
  • Table 94. Canada Electrophoresis, by Type USD Million (2013-2018)
  • Table 95. Canada Electrophoresis, by Application USD Million (2013-2018)
  • Table 96. Canada Electrophoresis, by End Users USD Million (2013-2018)
  • Table 97. Mexico Electrophoresis, by Type USD Million (2013-2018)
  • Table 98. Mexico Electrophoresis, by Application USD Million (2013-2018)
  • Table 99. Mexico Electrophoresis, by End Users USD Million (2013-2018)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Electrophoresis: by Type(USD Million)
  • Table 111. Electrophoresis Electrophoresis Reagents , by Region USD Million (2019-2024)
  • Table 112. Electrophoresis Gel Electrophoresis Systems (Horizontal Gel Electrophoresis Instrument, Vertical Gel Electrophoresis Instrument, Polyacrylamide Gel Electrophoresis, Agarose Gel Electrophoresis) , by Region USD Million (2019-2024)
  • Table 113. Electrophoresis Capillary Electrophoresis Systems , by Region USD Million (2019-2024)
  • Table 114. Electrophoresis Gel Documentation Systems , by Region USD Million (2019-2024)
  • Table 115. Electrophoresis Software , by Region USD Million (2019-2024)
  • Table 116. Electrophoresis: by Application(USD Million)
  • Table 117. Electrophoresis Diagnostic , by Region USD Million (2019-2024)
  • Table 118. Electrophoresis Research , by Region USD Million (2019-2024)
  • Table 119. Electrophoresis Quality Control , by Region USD Million (2019-2024)
  • Table 120. Electrophoresis Process Validation , by Region USD Million (2019-2024)
  • Table 121. Electrophoresis: by End Users(USD Million)
  • Table 122. Electrophoresis Academic Institutions , by Region USD Million (2019-2024)
  • Table 123. Electrophoresis Hospitals & Diagnostic Centers , by Region USD Million (2019-2024)
  • Table 124. Electrophoresis Pharmaceutical & Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 125. Electrophoresis Research Organizations , by Region USD Million (2019-2024)
  • Table 126. South America Electrophoresis, by Country USD Million (2019-2024)
  • Table 127. South America Electrophoresis, by Type USD Million (2019-2024)
  • Table 128. South America Electrophoresis, by Application USD Million (2019-2024)
  • Table 129. South America Electrophoresis, by End Users USD Million (2019-2024)
  • Table 130. Brazil Electrophoresis, by Type USD Million (2019-2024)
  • Table 131. Brazil Electrophoresis, by Application USD Million (2019-2024)
  • Table 132. Brazil Electrophoresis, by End Users USD Million (2019-2024)
  • Table 133. Argentina Electrophoresis, by Type USD Million (2019-2024)
  • Table 134. Argentina Electrophoresis, by Application USD Million (2019-2024)
  • Table 135. Argentina Electrophoresis, by End Users USD Million (2019-2024)
  • Table 136. Rest of South America Electrophoresis, by Type USD Million (2019-2024)
  • Table 137. Rest of South America Electrophoresis, by Application USD Million (2019-2024)
  • Table 138. Rest of South America Electrophoresis, by End Users USD Million (2019-2024)
  • Table 139. Asia Pacific Electrophoresis, by Country USD Million (2019-2024)
  • Table 140. Asia Pacific Electrophoresis, by Type USD Million (2019-2024)
  • Table 141. Asia Pacific Electrophoresis, by Application USD Million (2019-2024)
  • Table 142. Asia Pacific Electrophoresis, by End Users USD Million (2019-2024)
  • Table 143. China Electrophoresis, by Type USD Million (2019-2024)
  • Table 144. China Electrophoresis, by Application USD Million (2019-2024)
  • Table 145. China Electrophoresis, by End Users USD Million (2019-2024)
  • Table 146. Japan Electrophoresis, by Type USD Million (2019-2024)
  • Table 147. Japan Electrophoresis, by Application USD Million (2019-2024)
  • Table 148. Japan Electrophoresis, by End Users USD Million (2019-2024)
  • Table 149. India Electrophoresis, by Type USD Million (2019-2024)
  • Table 150. India Electrophoresis, by Application USD Million (2019-2024)
  • Table 151. India Electrophoresis, by End Users USD Million (2019-2024)
  • Table 152. South Korea Electrophoresis, by Type USD Million (2019-2024)
  • Table 153. South Korea Electrophoresis, by Application USD Million (2019-2024)
  • Table 154. South Korea Electrophoresis, by End Users USD Million (2019-2024)
  • Table 155. Taiwan Electrophoresis, by Type USD Million (2019-2024)
  • Table 156. Taiwan Electrophoresis, by Application USD Million (2019-2024)
  • Table 157. Taiwan Electrophoresis, by End Users USD Million (2019-2024)
  • Table 158. Australia Electrophoresis, by Type USD Million (2019-2024)
  • Table 159. Australia Electrophoresis, by Application USD Million (2019-2024)
  • Table 160. Australia Electrophoresis, by End Users USD Million (2019-2024)
  • Table 161. Rest of Asia-Pacific Electrophoresis, by Type USD Million (2019-2024)
  • Table 162. Rest of Asia-Pacific Electrophoresis, by Application USD Million (2019-2024)
  • Table 163. Rest of Asia-Pacific Electrophoresis, by End Users USD Million (2019-2024)
  • Table 164. Europe Electrophoresis, by Country USD Million (2019-2024)
  • Table 165. Europe Electrophoresis, by Type USD Million (2019-2024)
  • Table 166. Europe Electrophoresis, by Application USD Million (2019-2024)
  • Table 167. Europe Electrophoresis, by End Users USD Million (2019-2024)
  • Table 168. Germany Electrophoresis, by Type USD Million (2019-2024)
  • Table 169. Germany Electrophoresis, by Application USD Million (2019-2024)
  • Table 170. Germany Electrophoresis, by End Users USD Million (2019-2024)
  • Table 171. France Electrophoresis, by Type USD Million (2019-2024)
  • Table 172. France Electrophoresis, by Application USD Million (2019-2024)
  • Table 173. France Electrophoresis, by End Users USD Million (2019-2024)
  • Table 174. Italy Electrophoresis, by Type USD Million (2019-2024)
  • Table 175. Italy Electrophoresis, by Application USD Million (2019-2024)
  • Table 176. Italy Electrophoresis, by End Users USD Million (2019-2024)
  • Table 177. United Kingdom Electrophoresis, by Type USD Million (2019-2024)
  • Table 178. United Kingdom Electrophoresis, by Application USD Million (2019-2024)
  • Table 179. United Kingdom Electrophoresis, by End Users USD Million (2019-2024)
  • Table 180. Netherlands Electrophoresis, by Type USD Million (2019-2024)
  • Table 181. Netherlands Electrophoresis, by Application USD Million (2019-2024)
  • Table 182. Netherlands Electrophoresis, by End Users USD Million (2019-2024)
  • Table 183. Rest of Europe Electrophoresis, by Type USD Million (2019-2024)
  • Table 184. Rest of Europe Electrophoresis, by Application USD Million (2019-2024)
  • Table 185. Rest of Europe Electrophoresis, by End Users USD Million (2019-2024)
  • Table 186. MEA Electrophoresis, by Country USD Million (2019-2024)
  • Table 187. MEA Electrophoresis, by Type USD Million (2019-2024)
  • Table 188. MEA Electrophoresis, by Application USD Million (2019-2024)
  • Table 189. MEA Electrophoresis, by End Users USD Million (2019-2024)
  • Table 190. Middle East Electrophoresis, by Type USD Million (2019-2024)
  • Table 191. Middle East Electrophoresis, by Application USD Million (2019-2024)
  • Table 192. Middle East Electrophoresis, by End Users USD Million (2019-2024)
  • Table 193. Africa Electrophoresis, by Type USD Million (2019-2024)
  • Table 194. Africa Electrophoresis, by Application USD Million (2019-2024)
  • Table 195. Africa Electrophoresis, by End Users USD Million (2019-2024)
  • Table 196. North America Electrophoresis, by Country USD Million (2019-2024)
  • Table 197. North America Electrophoresis, by Type USD Million (2019-2024)
  • Table 198. North America Electrophoresis, by Application USD Million (2019-2024)
  • Table 199. North America Electrophoresis, by End Users USD Million (2019-2024)
  • Table 200. United States Electrophoresis, by Type USD Million (2019-2024)
  • Table 201. United States Electrophoresis, by Application USD Million (2019-2024)
  • Table 202. United States Electrophoresis, by End Users USD Million (2019-2024)
  • Table 203. Canada Electrophoresis, by Type USD Million (2019-2024)
  • Table 204. Canada Electrophoresis, by Application USD Million (2019-2024)
  • Table 205. Canada Electrophoresis, by End Users USD Million (2019-2024)
  • Table 206. Mexico Electrophoresis, by Type USD Million (2019-2024)
  • Table 207. Mexico Electrophoresis, by Application USD Million (2019-2024)
  • Table 208. Mexico Electrophoresis, by End Users USD Million (2019-2024)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Electrophoresis: by Type USD Million (2013-2018)
  • Figure 5. Global Electrophoresis: by Application USD Million (2013-2018)
  • Figure 6. Global Electrophoresis: by End Users USD Million (2013-2018)
  • Figure 7. South America Electrophoresis Share (%), by Country
  • Figure 8. Asia Pacific Electrophoresis Share (%), by Country
  • Figure 9. Europe Electrophoresis Share (%), by Country
  • Figure 10. MEA Electrophoresis Share (%), by Country
  • Figure 11. North America Electrophoresis Share (%), by Country
  • Figure 12. Global Electrophoresis share by Players 2018 (%)
  • Figure 13. Global Electrophoresis share by Players (Top 3) 2018(%)
  • Figure 14. Global Electrophoresis share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Bio-Rad Laboratories (United States) Revenue: by Geography 2018
  • Figure 18. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 19. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 20. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2018
  • Figure 22. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 24. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 25. Agilent Technologies (United States) Revenue: by Geography 2018
  • Figure 26. Merck Millipore (United States) Revenue, Net Income and Gross profit
  • Figure 27. Merck Millipore (United States) Revenue: by Geography 2018
  • Figure 28. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. PerkinElmer, Inc. (United States) Revenue: by Geography 2018
  • Figure 30. QIAGEN N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 31. QIAGEN N.V. (Germany) Revenue: by Geography 2018
  • Figure 32. Lonza Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Lonza Group Ltd. (Switzerland) Revenue: by Geography 2018
  • Figure 34. Shimadzu Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Shimadzu Corporation (Japan) Revenue: by Geography 2018
  • Figure 36. Global Electrophoresis: by Type USD Million (2019-2024)
  • Figure 37. Global Electrophoresis: by Application USD Million (2019-2024)
  • Figure 38. Global Electrophoresis: by End Users USD Million (2019-2024)
  • Figure 39. South America Electrophoresis Share (%), by Country
  • Figure 40. Asia Pacific Electrophoresis Share (%), by Country
  • Figure 41. Europe Electrophoresis Share (%), by Country
  • Figure 42. MEA Electrophoresis Share (%), by Country
  • Figure 43. North America Electrophoresis Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Bio-Rad Laboratories (United States)
  • GE Healthcare (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Danaher Corporation (United States)
  • Agilent Technologies (United States)
  • Merck Millipore (United States)
  • PerkinElmer, Inc. (United States)
  • QIAGEN N.V. (Germany)
  • Lonza Group Ltd. (Switzerland)
  • Shimadzu Corporation (Japan)
Additional players considered in the study are as follows:
Harvard Bioscience, Inc. (United Sates) , C.B.S. Scientific Company, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation